Taken together, our study, which integrated clinical, population-based, and computational data, provides a more comprehensive view of the potential functional and clinical impact of BRCA2 variants in Mexican patients with breast and ovarian cancer. The gene discussed is BRCA2; the disease is ovarian cancer.